Company
VivioMD
VivioMD publishes unspecified GLP-1 and brand semaglutide, from $299 to $1,299 a month.
- 3 programs
- 2 molecules
- 6 readings
Read from viviomd.com on September 3, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to VivioMD
We earn nothing from this link. VivioMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · GLP-1 Tablets, starting price
first month, including the required fees on record · GLP-1 Injections, starting price
first month, including the required fees on record · Ozempic, starting price
Terms
| Membership | Not disclosed |
|---|---|
| States | All states except Louisiana |
Not yet checked: pharmacy and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. The site contradicts itself on coverage: homepage claims 'Licensed Providers in All 50 States' while the Terms of Use say 49 states, excluding Louisiana — recorded the more specific Terms of Use statement per the brief's exclusion-list rule (list left empty). The terms-of-use page also contains a stray internal editorial bracket ('[KEEP the remaining standard sections unchanged from the new-site Terms ... these are legal boilerplate and unchanged — the new-site versions are clean.]') that reads like a leaked AI-drafting instruction left live on the public page by mistake — not acted on, just noted as a curiosity. None of the four priced tiles name a specific vial/pen form.
Before you act
Cite this
Treatment Registry. (2026). VivioMD: recorded programs and prices. Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/viviomd